| Document |
Document Title |
|
WO/2016/163276A1 |
[Problem] To provide an organic electroluminescent element which has low driving voltage, high luminous efficiency and a long service life by combining various materials for organic electroluminescent elements having excellent injection/...
|
|
WO/2016/159085A1 |
The present invention provides a method for producing a Mo-, V-, Sb-, and Nb-containing oxide catalyst used in a vapor-phase-contact oxidation reaction or vapor-phase-contact ammoxidation reaction of propane or isobutane, wherein the met...
|
|
WO/2016/152964A1 |
The present invention provides a method for producing a catalyst that is used for a vapor-phase catalytic ammoxidation reaction of propane. This method comprises: a blending step for obtaining a starting material blended liquid by dissol...
|
|
WO/2016/147950A1 |
This catalyst packing method includes a step in which the packing of a catalyst into a fluidized bed reactor is initiated while introducing a gas into the fluidized bed reactor so as to result in a gas flow velocity inside the fluidized ...
|
|
WO/2016/143634A1 |
Provided is a bimesogenic compound which exhibits high solubility in other bimesogenic compounds and substances used in conventional liquid crystal display elements, such as liquid crystalline compounds, liquid crystal compositions, chir...
|
|
WO/2016/144825A1 |
Aromatic entities that modulate HIF-2α activity, pharmaceutical compositions containing the aromatic entities, and methods of using these chemical entities for treating proliferative diseases and conditions associated with HIF-2α activ...
|
|
WO/2016/144667A2 |
A method includes reacting, at a first pressure and in the presence of a catalyst, ammonia, oxygen, and a hydrocarbon selected from the group consisting of propane, propylene and isobutylene, and combinations thereof, to provide a reacto...
|
|
WO/2016/144664A2 |
A method includes reacting, at a first pressure and in the presence of a catalyst, ammonia, oxygen, and a hydrocarbon selected from the group consisting of propane, propylene and isobutylene, and combinations thereof, to provide a reacto...
|
|
WO/2016/139373A1 |
Molecular storage materials for incorporating small molecules in solid matrices may find applications in structure elucidation, decontamination, and slow release of active ingredients. The syntheses of 1,3,5,7-tetrakis(2,4-dimethoxypheny...
|
|
WO/2016/139355A1 |
The invention relates to a compound of Formula (I) and its use as a selective dipeptidyl peptidase I inhibitor, as well as pharmaceutical compositions comprising said compound, and methods of treatment involving said compound.
|
|
WO/2016/135151A1 |
The present invention relates to the fields of organic electronics and photonics. More particularly, the present invention relates to fluorescent charge-transfer compounds emitting in the visible spectral range from blue to red, comprisi...
|
|
WO/2016/135070A1 |
The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are as described herein, compositions including the compounds and methods of using the compounds.
|
|
WO/2016/116555A1 |
A new process for the production of 2-[4-(cyclopropanecarbonyl)phenyl]-2-methyl- propanenitrile is described. This compound can be used for the production of drugs, such as Fexofenadine.
|
|
WO/2016/111347A1 |
Provided is a drug the active ingredient of which is a compound having antagonistic activity against EP4 receptor in the prevention and/or treatment of disease attributed to activation of EP4 receptor. The compound represented by general...
|
|
WO/2016/111140A1 |
A photoelectric conversion element wherein: at least one organic layer is present between a first electrode and a second electrode; and the organic layer contains at least two compounds in combination, said two compounds having the same ...
|
|
WO/2016/108282A1 |
A compound represented by general formula (III), and the use of a tautomer or stereoisomer of said compound, or a pharmacologically acceptable salt or solvate thereof, as a treatment for gout or hyperuricemia. (III) (In the formula, R1a,...
|
|
WO/2016/108269A1 |
The present invention provides a compound represented by general formula (1).(In the formula, A1 is an optionally substituted aromatic hydrocarbon ring group or an optionally substituted aromatic heterocyclic group, A2 is a direct bond, ...
|
|
WO/2016/106377A1 |
Three-dimensional structures of stably associated mesogenic ligand-functionalized nanoparticles are provided. Compositions that include these structures, as well as methods of making the structures are also provided. The structures, comp...
|
|
WO/2016/104707A1 |
[Problem] The purpose of the invention is to provide a compound that can be utilized as an antiviral agent, in particular as an anti-RNA viral agent, and especially as an anti-RS viral agent. [Solution] The invention provides a compound ...
|
|
WO/2016/102494A1 |
The present invention relates to alanine N-acetic acid precursors of formula (i) COOM-CH(CH3)-NH-(CH2CN), wherein M is hydrogen (alanine N-monoacetonitrile), or (ii) COOM-CH(CH3)-N-(CH2CN)2, wherein 0 to 50% of all M is sodium or potassi...
|
|
WO/2016/100259A1 |
A phthalonitrile compound having the formula below. The value n is a positive integer. Each R has a hydrocarbon chain optionally having -O- or -SiR'2-O-. Each R' is an aliphatic group. Each Ar is an aromatic group with the proviso that A...
|
|
WO/2016/097017A1 |
The present invention relates to a process for preparation of an electrically doped semiconducting material comprising a [3]-radialene p-dopant or for preparation of an electronic device containing a layer comprising a [3]-radialene p-do...
|
|
WO/2016/091699A1 |
The present invention concerns compound of formula (I) in the form of any one of its stereoisomers or a mixture thereof, and wherein R1 and R1', independently from each other, represent a hydrogen atom or a methyl group provided that one...
|
|
WO/2016/093175A1 |
According to the present invention, various tri(hetero)arylacetonitrile compounds are synthesized by reacting, in the presence of a palladium catalyst, a di(hetero)arylacetonitrile compound represented by the formula: CHAr1Ar2CN (Ar1 and...
|
|
WO/2016/086885A1 |
Disclosed are a deuterated organic compound, a mixture and composition containing said compound, and an organic electronic device; the deuterated organic compound has the structural formula (I): an aromatic or heteroaromatic structural u...
|
|
WO/2016/082798A1 |
Disclosed are an α-cyan-4-hydroxycinnamic acid derivative having aldose reductase (AR) inhibitory activity and a preparation method and use thereof, the compound having a structure as represented by formula I, and the preparation method...
|
|
WO/2016/075605A1 |
The present invention provides a process for the preparation of crystalline anhydrous compound of Formula (X), Further, the present invention relates to the use of compound of Formula (X) preparation of Raltegravir (I) or its pharmaceuti...
|
|
WO/2016/074225A1 |
Provided is a method for resolution of formula 4-[4-dimethylamino-1-(4-fluorophenyl)-1-hydroxylbutyl]-3-hyd
roxymethyl cyanophenyl as an enantiomer thereof, comprising the following steps: crystallizing, in a resolving solvent, a salt fo...
|
|
WO/2016/073774A2 |
Compounds that modulate the oxidoreductase enzyme indoleamine 2,3- dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse ...
|
|
WO/2016/068068A1 |
Disclosed is a method for producing acetonitrile, the method comprising: a gas-phase reaction step for obtaining hydrous crude acetonitrile by subjecting acetic acid and ammonia to a gas-phase reaction in the presence of a solid acid cat...
|
|
WO/2016/065930A1 |
Novel crystal forms of (R) - (+) -verapamil hydrochloride are disclosed.
|
|
WO/2016/066574A1 |
Disclosed are compounds of formula (I) which possess anthelminthic properties wherein the structural elements have the meaning as indicated in the description. Further disclosed are such compounds for the control, treatment and/or preven...
|
|
WO/2016/068061A1 |
Disclosed is a method for producing acetonitrile, the method comprising a gas-phase reaction step for obtaining hydrous crude acetonitrile by subjecting acetic acid and ammonia to a gas-phase reaction in the presence of a zeolite catalys...
|
|
WO/2016/068062A1 |
A method for producing acetonitrile by performing a gas-phase reaction step for obtaining water-containing crude acetonitrile by subjecting acetic acid and ammonia to a gas-phase reaction while in the presence of a catalyst containing a ...
|
|
WO/2016/062585A1 |
The present invention relates to a compound of formula (I) wherein: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and G are as defined herein; and wherein the compound of formula (I) is optionally present as an agrochemically acce...
|
|
WO/2016/058504A1 |
An aromatic amine derivative as shown in the general formula I and a synthesis method and use thereof and an organic electroluminescent device. The compound has a symmetrical structure, is easy to synthesize, has a relatively high molecu...
|
|
WO/2016/053559A1 |
A process and system for removing heavy organic impurities from a process stream includes providing a process stream having water and about 0.5 to about 1.5 weight percent heavy organic impurities. The process includes separating water f...
|
|
WO/2016/053549A1 |
Processes are provided for quench column operation and bottom processing. A process for providing an ammonium sulfate stream includes conveying a reactor effluent to a quench column; and conveying sulfuric acid to the quench column to pr...
|
|
WO/2016/050988A1 |
The present invention relates to a process for preparing a compound having the formula (I), said process comprising the following steps: a) the addition of an oxygen source into a solution of a compound of formula (II), in a water-miscib...
|
|
WO/2016/041930A1 |
A method is described for continuous production of adiponitrile by hydrocyanation of 3-pentenenitrile in which a) 3-pentenenitrile is hydrocyanized to yield a reaction discharge which contains adiponitrile, b) in a work-up 1 of the react...
|
|
WO/2016/039393A1 |
The purpose of the present invention is to provide a method for high-yield, inexpensive, and safe industrial production of a lacosamide having high optical purity. The present invention addresses said issue by providing a method for high...
|
|
WO/2016/028897A1 |
A perfume composition comprising an effective amount of at least one alkadienenitrile selected from 4,8-undecadienenitrile and isomers thereof, 4,9- dodecadienenitrile and isomers thereof, and 4,10-tridecadienenitrile and isomers thereof...
|
|
WO/2016/020603A1 |
Process for producing a calix-[z]-arene in which: - a calix-[z]-arene in which R1=R2=R3=R4=X1=X2=X3=X4=H is supplied, - step (a): - this calix-[z]-arene is treated with an alkylating agent transmitting the R4 residue, so as to obtain a r...
|
|
WO/2016/012362A1 |
The invention relates to cyano cycloalkyl penta-2,4-dienes, cyano cycloalkyl pent-2-en-4-ynes, cyano heterocyclyl penta-2,4-dienes and cyano heterocyclyl pent-2-en-4-ynes of general formula (I), or the salts thereof, where [X-Y], Q, R1, ...
|
|
WO/2016/008862A1 |
The invention relates to substituted vinyl and alkynyl cyanocycloalkanols and vinyl and alkynyl cyanoheterocyclylalkanols of general formula (I) or the salts thereof, wherein [X-Y], Q, R1, R2, A1, A2, V, W, m and n have the definitions s...
|
|
WO/2016/001110A1 |
The present invention relates to a process for producing 2-propionylalkanonitriles of the formula (I) wherein R is C4-C16-alkyl, in particular C6-C10-alkyl, especially n-octyl. The present invention relates in particular to the productio...
|
|
WO/2016/003917A1 |
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. ...
|
|
WO/2015/200597A1 |
Disclosed herein are methods for recovering phosphorus-containing ligand from mixtures comprising organic mononitriles and organic dinitriles, using liquid-liquid extraction. Also disclosed are treatments to enhance extractability of the...
|
|
WO/2015/199167A1 |
Provided is a method for producing a substituted spiropyrido[1,2-a]pyrazine derivative, or a salt thereof, that are useful as anti-HIV agents. Also provided is a production intermediate. Compound [VIII] is obtained by reacting compound [...
|
|
WO/2015/193255A1 |
The present invention is directed to novel compounds of Formula (I), pharmaceutically acceptable salts or solvates thereof, and their use.
|
